World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
60
Citations
10773
World Ranking
3174
National Ranking
1254

Karl V. Clemons publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Karl V. Clemons sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 232 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Karl V. Clemons D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Karl V. Clemons sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 60 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Karl V. Clemons is affiliated with Stanford University in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in Infectious Diseases, Epidemiology, Small Animals, Pulmonary and Respiratory Medicine, and Plant Science.

Their work covers a range of topics including:

  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Infectious Diseases and Mycology
  • Nail Diseases and Treatments
  • Cystic Fibrosis Research Advances
  • Nematode management and characterization studies

Karl V. Clemons has authored several recent papers published in respected journals. These include:

  • Interplay of Cytokines and Chemokines in Aspergillosis, 2024, Journal of Fungi
  • Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis, 2021, Antimicrobial Agents and Chemotherapy
  • Protective Role of CFTR during Fungal Infection of Cystic Fibrosis Bronchial Epithelial Cells with Aspergillus fumigatus, 2023, Frontiers in Cellular and Infection Microbiology

Frequent co-authors with whom they have collaborated on multiple occasions include:

  • David A. Stevens
  • Gabriele Sass
  • Jata Shankar
  • Raman Thakur
  • Laura Kovanda

The venues where Karl V. Clemons regularly publishes include:

  • Journal of Fungi
  • Antimicrobial Agents and Chemotherapy
  • Frontiers in Cellular and Infection Microbiology

Best Publications

  • Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth

    James Kim;Jean Y. Tang;Jean Y. Tang;Ruoyu Gong;Jynho Kim

  • Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea

    Michael J. McCullough;Karl V. Clemons;David A. Stevens

  • Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.

    Eveline C van Asbeck;Karl V Clemons;David A Stevens

  • Genetic Characterization of Pathogenic Saccharomyces Cerevisiae Isolates

    J H McCusker;K V Clemons;D A Stevens;R W Davis

  • Comparative Efficacies of Conventional Amphotericin B, Liposomal Amphotericin B (AmBisome), Caspofungin, Micafungin, and Voriconazole Alone and in Combination against Experimental Murine Central Nervous System Aspergillosis

    Karl V. Clemons;Karl V. Clemons;Marife Espiritu;Rachana Parmar;David A. Stevens;David A. Stevens

  • Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis.

    K V Clemons;E Brummer;D A Stevens

  • Restriction Endonuclease Analysis of Total Cellular DNA of Aspergillus fumigatus Isolates of Geographically and Epidemiologically Diverse Origin

    David W. Denning;Karl V. Clemons;Linda H. Hanson;David A. Stevens

  • Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source,and review of published studies

    Eveline C. van Asbeck;Eveline C. van Asbeck;Eveline C. van Asbeck;Yhu-Chering Huang;Angela N. Markham;Angela N. Markham;Karl V. Clemons;Karl V. Clemons

  • Hormones and the Resistance of Women to Paracoccidioidomycosis

    Jata Shankar;Jata Shankar;Angela Restrepo;Karl V. Clemons;Karl V. Clemons;David A. Stevens;David A. Stevens

  • Species Identification and Virulence Attributes of Saccharomyces boulardii (nom. inval.)

    Michael J. McCullough;Karl V. Clemons;Karl V. Clemons;John H. McCusker;David A. Stevens;David A. Stevens

  • Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42 degrees C and form pseudohyphae.

    J H McCusker;K V Clemons;D A Stevens;R W Davis

  • Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis.

    K. V. Clemons;G. Grunig;R. A. Sobel;L. F. Mirels

  • Comparative Pathogenesis of Clinical and Nonclinical Isolates of Saccharomyces cerevisiae

    Karl V. Clemons;John H. McCusker;Ronald W. Davis;David A. Stevens

  • Efficacy of Micafungin Alone or in Combination against Systemic Murine Aspergillosis

    Javier Capilla Luque;Karl V. Clemons;Karl V. Clemons;David A. Stevens;David A. Stevens

  • Assessment of the Paradoxical Effect of Caspofungin in Therapy of Candidiasis

    Karl V. Clemons;Marife Espiritu;Rachana Parmar;David A. Stevens;David A. Stevens

  • Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.

    J E Lutz;K V Clemons;B H Aristizabal;D A Stevens

  • Comparative analysis of genetic variability among Candida albicans isolates from different geographic locales by three genotypic methods.

    K V Clemons;F Feroze;K Holmberg;D A Stevens

  • Comparison of Fungizone, Amphotec, AmBisome, and Abelcet for Treatment of Systemic Murine Cryptococcosis

    Karl V. Clemons;David A. Stevens

  • The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence

    K. V. Clemons;K. V. Clemons;D. A. Stevens;D. A. Stevens

  • Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations.

    J S Hostetler;J Heykants;K V Clemons;R Woestenborghs

Frequent Co-Authors

David A. Stevens
David A. Stevens Stanford University
Raymond A. Sobel
Raymond A. Sobel Stanford University
Lisa A. Tell
Lisa A. Tell University of California, Davis
John H. McCusker
John H. McCusker Duke University
Demosthenes Pappagianis
Demosthenes Pappagianis University of California, Davis
Elmer Brummer
Elmer Brummer Santa Clara Valley Medical Center
Malcolm Richardson
Malcolm Richardson University of Manchester
Richard B. Moss
Richard B. Moss Stanford University
Ronald W. Davis
Ronald W. Davis Stanford University
David Feldman
David Feldman Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various interdisciplinary fields, some of which can be pursued through online healthcare degrees. These programs offer flexibility for students balancing work or personal commitments while gaining essential medical knowledge that complements microbiology expertise.

For those interested in public health aspects of microbiology, exploring mph online programs with easy admission requirements can provide an accessible pathway. These programs blend epidemiology, disease prevention, and policy, aligning well with microbiological principles in real-world health challenges.

Career pathways like becoming a certified child life specialist may also intrigue microbiology graduates who want to work in healthcare environments supporting patients and families. Understanding the process of ccls certification can be a valuable step toward this meaningful profession.

Moreover, students with unique backgrounds might wonder, what is the best degree for a convicted felon. Fortunately, many online programs and career options accommodate non-traditional students, including those with criminal records, helping them build rewarding careers in science and healthcare.

Best Scientists Citing Karl V. Clemons

Trending Scientists

Recently Published Articles